Evaluation of Moving On: a self management program for people with a chronic illness
Project Short Title | Project Number |
Project Coordinator
Anna Williams
Chief Investigators
Anna Williams, Mark Harris
Associate Investigators
Leah Bloomfield, Diana Aspinall, Neil Orr
Rationale
Support for Chronic Disease Self Management (CDSM) is a recognized part of chronic disease management. Many disease specific chronic disease self management programs exist internationally. There are currently only two generic CDSM programs that have been evaluated internationally: (1) the Lorig Program (Stanford University, US) and (2) the Expert Patient Model (UK). This study will evaluate using a randomized control trial an Australian designed generic chronic disease self management program, with the potential of widespread applicability to clinicians internationally working in chronic disease management.
Aims
The evaluation aims to ascertain the impact of the Moving On Program on participants in regards to knowledge and skills for self management, attainment of selected goals, behaviour change and perceived improvements in health status. The evaluation has four research questions: (1) Does participation in the Program result in a significantly greater improvement in self management knowledge and behaviour in clients from the intervention group compared to the control group? (2) To what extent does participation in the Program result in a greater improvement in self efficacy and positive psychological attitude than participation in the control group? (3) Does participation in the Program result in a greater improvement in perceived health status? (4) Does the Program have any negative impacts and are these greater in participants attending the Program compared to those in the control group?
Design and Method
Two-arm randomised control trial. A rural and metropolitan arm. Methods include (1) Pre-test study (Sept-Dec 07) (2) Pilot Study (Jun -Sept 2008); (3) RCT. Blocks of randomisation will be used to allocate clients to the intervention or control group. Data will be collected using validated tools at baseline and four months following the Program. The Program is due for completion early 2010.